760 related articles for article (PubMed ID: 18618522)
1. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.
Comelli F; Giagnoni G; Bettoni I; Colleoni M; Costa B
Phytother Res; 2008 Aug; 22(8):1017-24. PubMed ID: 18618522
[TBL] [Abstract][Full Text] [Related]
2. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.
Costa B; Trovato AE; Comelli F; Giagnoni G; Colleoni M
Eur J Pharmacol; 2007 Feb; 556(1-3):75-83. PubMed ID: 17157290
[TBL] [Abstract][Full Text] [Related]
3. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
4. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
[TBL] [Abstract][Full Text] [Related]
6. Milnacipran attenuates hyperalgesia and potentiates antihyperalgesic effect of tramadol in rats with mononeuropathic pain.
Onal A; Parlar A; Ulker S
Pharmacol Biochem Behav; 2007 Dec; 88(2):171-8. PubMed ID: 17854875
[TBL] [Abstract][Full Text] [Related]
7. Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors.
Gutierrez VP; Konno K; Chacur M; Sampaio SC; Picolo G; Brigatte P; Zambelli VO; Cury Y
Eur J Pharmacol; 2008 Oct; 594(1-3):84-92. PubMed ID: 18703042
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress.
Comelli F; Bettoni I; Colleoni M; Giagnoni G; Costa B
Phytother Res; 2009 Dec; 23(12):1678-84. PubMed ID: 19441010
[TBL] [Abstract][Full Text] [Related]
11. (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.
Fride E; Feigin C; Ponde DE; Breuer A; Hanus L; Arshavsky N; Mechoulam R
Eur J Pharmacol; 2004 Dec; 506(2):179-88. PubMed ID: 15588739
[TBL] [Abstract][Full Text] [Related]
12. Analgesic properties of the novel compound M43068 in rat models of acute and neuropathic pain.
Akada Y; Mori R; Kato Y; Yamasaki F; Mochizuki H
Eur J Pharmacol; 2005 Oct; 523(1-3):46-53. PubMed ID: 16226249
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid transmission and pain perception.
Martin BR; Lichtman AH
Neurobiol Dis; 1998 Dec; 5(6 Pt B):447-61. PubMed ID: 9974177
[TBL] [Abstract][Full Text] [Related]
16. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
17. Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.
Guindon J; Desroches J; Dani M; Beaulieu P
Eur J Pharmacol; 2007 Jul; 568(1-3):173-6. PubMed ID: 17555742
[TBL] [Abstract][Full Text] [Related]
18. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
[TBL] [Abstract][Full Text] [Related]
19. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis (lemon balm) in mice.
Guginski G; Luiz AP; Silva MD; Massaro M; Martins DF; Chaves J; Mattos RW; Silveira D; Ferreira VM; Calixto JB; Santos AR
Pharmacol Biochem Behav; 2009 Jul; 93(1):10-6. PubMed ID: 19358864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
